The applicant who lost a class action against animal health giant Zoetis over alleged side effects resulting from its Hendra virus horse vaccine has filed an appeal, arguing the judge should have found the vaccine was not of acceptable quality.
The founder of investment group Mayfair 101 must foot half his costs of a successful appeal of a 20-year ban on fund raising because of the many “spurious” grounds of appeal he pressed.
The ACT Government is looking for a legal expert to head up a new inquiry into the trial of Bruce Lehrmann over the alleged rape of former liberal staffer Brittany Higgins, which will investigate the conduct of police investigators and prosecutors.
A law firm has lost its bid to challenge a court order that it join forces with a competing firm in an investor class action against Blue Sky Alternative Investments and auditor EY.
The High Court won’t hear an appeal by payday loan providers Cigna and BHF seeking to challenge a Full Court judgment that found they can’t dodge the obligations contained in the National Credit Code through their lending model.
Insurer Allianz has won its challenge to a decision forcing it to indemnify a north Queensland body corporate for cyclone damage despite non-disclosure of serious building defects, with the High Court finding insurers have no general duty to be “decent and fair”.
The High Court has found that property data analytics firm CoreLogic did not infringe a real estate photographer’s copyright by uploading images from realestate.com.au to its platform, overturning a decision of the Full Federal Court.
Nine has mostly lost its bid to shield documents produced under subpoena in a defamation case brought over A Current Affair’s coverage of barrister Gina Edwards’ custody battle for famed social media pooch Oscar the cavoodle.
A Sydney barrister was embarrassed and afraid to return to chambers following Channel Nine’s allegedly defamatory coverage of her custody battle for famed social media pooch Oscar the cavoodle, a court has heard.
A contradictor has argued that the High Court must consider the reputation of Botox maker Allergan’s trade marks in a cosmetic company’s challenge to a judgment finding it infringed the marks by marketing its topical creams as Botox alternatives.